Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma-Reference-Cited by-同舟云学术

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma

Published:2012-11-20 Issue:2 Volume:160 Page:207-215
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Corazzelli Gaetano¹,Angrilli Francesco²,D'Arco Alfonso³,Ferrara Felicetto⁴,Musto Pellegrino⁵,Guarini Attilio⁶,Cox Maria Christina⁷,Stelitano Caterina⁸,Storti Sergio⁹,Iannitto Emilio¹⁰,Falorio Simona²,Califano Catello³,Amore Alfonso¹¹,Arcamone Manuela¹,De Filippi Rosaria,Pinto Antonio¹

Affiliation:

1. Haematology-Oncology and Stem Cell Transplantation Unit; Department of Haematology; Fondazione ‘G. Pascale’; IRCCS; Naples; Italy

2. Department of Haematology; Santo Spirito Hospital; Pescara; Italy

3. Division of Oncology-Haematology; ‘Umberto I’ Hospital; Nocera Inferiore; Italy

4. Division of Haematology and Stem Cell Transplantation; Cardarelli Hospital; Naples; Italy

5. Department of Oncology-Haematology; IRCCS-CROB; Rionero in Vulture; Italy

6. Haematology Unit; Institute “Giovanni Paolo II”; IRCCS; Bari; Italy

7. Department of Haematology; University “La Sapienza”; S. Andrea Hospital; Rome; Italy

8. Division of Haematology; Ospedale ‘Bianchi-Melacrino-Morelli’; Reggio Calabria; Italy

9. Haematology Unit; Università Cattolica; Campobasso; Italy

10. Haematology Unit; Ospedale SS Annunziata; Taranto; Italy

11. Abdominal Surgery D; Fondazione ‘G. Pascale’; IRCCS; Naples; Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12120/fullpdf

Reference38 articles.

1. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape;Aldinucci;Journal of Pathology,2010

2. Bendamustine as a model for the activity of alkylating agents;Apostolopoulos;Future Oncology,2008

3. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma;Bauer;The Cochrane Database of Systematic Reviews,2011

4. Managing relapsed and refractory Hodgkin lymphoma;Brice;British Journal of Haematology,2008

5. Novel small-molecule therapy of Hodgkin lymphoma;Buglio;Expert Review of Anticancer Therapy,2007

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules;Cancer Letters;2024-06

2. The optimal management of relapsed and refractory Hodgkin lymphoma: post–brentuximab and checkpoint inhibitor failure;Hematology;2023-12-08

3. Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma;Blood Advances;2021-12-17

4. Electrochemical determination of anticancer drug Bendamustine and its interaction with double strand DNA in the absence and presence of quercetin;Colloids and Surfaces B: Biointerfaces;2021-09

5. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study;Archives of Medical Science;2021-07-16